Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s506, 2024. DOI: 10.25251/skin.8.supp.506. Disponível em: https://skin.dermsquared.com/skin/article/view/3076. Acesso em: 30 apr. 2026.